We recently published a list of 12 Stocks Jim Cramer Was Right About. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other stocks that Jim Cramer discusses.

Back in 2024, on May 16, a caller asked about Boston Scientific Corporation (NYSE:BSX), a medical device company. Cramer praised its cardio business and wished he had bought it back then:

“That company is just doing so well. They have an amazing cardio franchise. I wish I owned that for the trust. It is just fantastic. Great call — thank you.”Was Jim Cramer Right About Boston Scientific Corporation (BSX)?

A surgeon examining a patient's brain in an operating room, paramedics nearby.

Boston Scientific was a clear win for Cramer, rising 42.24% on the back of strong fundamentals.

Boston Scientific Corporation (NYSE:BSX) is thriving thanks to a strong product pipeline in cardiology and minimally invasive surgery.

Overall, BSX ranks 4th on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of BSX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BSX and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.

View Comments